Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Taro Hase"'
Autor:
Takashi Deguchi, Sayaka Yasuda, Satoshi Tamada, Kazuya Morimoto, Taro Iguchi, Yasuo Yamakoshi, Tetsuya Makino, Koji Harimoto, Taro Hase, Y. Machida, Tatsuya Nakatani, Minoru Kato, Keiichi Ishii, Tetsuji Ohmachi, Tomohiro Kanamaru, Takahisa Adachi, Yoshinori Takegaki, Shinji Yamamoto, Hiroyuki Iwata
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:In Japan, combined androgen blockade (CAB) with bicalutamide is widely used against advanced hormone-sensitive prostate cancer. Flutamide was widely used in clinical prac...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdbd24217432f0fb4567df1c900139d1
https://doi.org/10.1097/ju.0000000000001969.11
https://doi.org/10.1097/ju.0000000000001969.11
Autor:
Taro Iguchi, Satoshi Tamada, Minoru Kato, Sayaka Yasuda, Yuichi Machida, Tetsuji Ohmachi, Keiichi Ishii, Hiroyuki Iwata, Shinji Yamamoto, Tomohiro Kanamaru, Kazuya Morimoto, Taro Hase, Koichiro Tashiro, Koji Harimoto, Takashi Deguchi, Takahisa Adachi, Katsuki Iwamoto, Yoshinori Takegaki, Tatsuya Nakatani
Publikováno v:
International journal of clinical oncology. 25(3)
Before the androgen target therapy era, flutamide was widely used for castration-resistant prostate cancer in Japan. Enzalutamide is currently the recommended treatment; however, the efficacy and safety of enzalutamide and flutamide after combined an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c507460b3e95d353b2f0e86662ff005
https://pubmed.ncbi.nlm.nih.gov/31564004
https://pubmed.ncbi.nlm.nih.gov/31564004
Autor:
Taro Hase, Hiroyuki Iwata, Takashi Deguchi, Katsuki Iwamoto, Kazuya Morimoto, Takahisa Adachi, Satoshi Tamada, Minoru Kato, Tatsuya Nakatani, Taiyo Otoshi, Keiichi Ishii, Yoshinori Takegaki, Tetsuji Ohmachi, Koji Harimoto, Sayaka Yasuda, Tomohiro Kanamaru, Taro Iguchi, Koichiro Tashiro, Y. Machida, Shinji Yamamoto
Publikováno v:
Journal of Clinical Oncology. 37:5042-5042
5042 Background: In Asia, bicalutamide-combined androgen blockade (CAB) is widely used to treat metastatic or locally advanced prostate cancer. Enzalutamide (ENZA) shows benefits in men with metastatic and nonmetastatic castration-resistant prostate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ff1fd1e44744cd3923386bd533f71eb
https://doi.org/10.1200/jco.2019.37.15_suppl.5042
https://doi.org/10.1200/jco.2019.37.15_suppl.5042
Autor:
Y. Machida, Koji Harimoto, Sayaka Yasuda, Taro Hase, Taro Iguchi, Koichiro Tashiroro, Tetsuji Ohmachi, Yoshinori Takegaki, Hiroyuki Iwata, Tomohiro Kanamaru, Takahisa Adachi, Kazuya Morimoto, Katsuki Iwamoto, Tatsuya Nakatani, Satoshi Tamada, Minoru Kato, Keiichi Ishii, Shinji Yamamoto, Takashi Deguhi
Publikováno v:
Journal of Clinical Oncology. 37:168-168
168 Background: In Asia, including Japan, combined androgen blockade (CAB) therapy with bicalutamide is widely administered for metastatic prostate cancer. Alternative anti-androgen therapy (AAT) with flutamide after CAB therapy with bicalutamide was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eef3b4aa7acc81d6b44f2d4fa0382666
https://doi.org/10.1200/jco.2019.37.7_suppl.168
https://doi.org/10.1200/jco.2019.37.7_suppl.168
Autor:
Rikio Yoshimura, Yoshihiro Segawa, Hajime Sano, Tatsuya Nakatani, Yutaka Kawahito, Seiji Wada, Taro Hase, Makoto Mitsuhashi
Publikováno v:
Urology. 60:542-547
Objectives. To investigate the expression of peroxisome proliferator activator-receptor (PPAR)-alpha, beta, and gamma in human testicular cancer (TC) and normal testicular (NT) tissues, as well as the effects of the PPAR-gamma ligand. Recent studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed266fb2556341d68d93dcdaa17400e5
https://doi.org/10.1016/s0090-4295(02)01747-8
https://doi.org/10.1016/s0090-4295(02)01747-8
Autor:
Taketoshi Kishimoto, Rikio Yoshimura, Chikayoshi Masuda, Munenori Kyo, Hidenori Kawashima, Shinichi Ikemoto, Taro Hase, Seiji Wada, Y Watanabe
Publikováno v:
International Journal of Urology. 7:373-377
Background: Transurethral resection of the prostate (TURP) is the gold standard treatment for benign prostatic hyperplasia (BPH). Recently, less invasive transurethral laser prostatectomy, such as visual laser ablation (VLAP) or interstitial laser co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e95323c2640d1ee714e19bcffcff58e
https://doi.org/10.1046/j.1442-2042.2000.00214.x
https://doi.org/10.1046/j.1442-2042.2000.00214.x
Publikováno v:
Transplantation Proceedings. 37:370-372
The pathogenesis of ischemia-reperfusion (I/R) injury is known to involve cytokines and particularly surface adhesion molecules, the expression of which initiates the attachment of inflammatory cells. Cyclooxygenase (COX)–1 and COX-2 catalyze the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91dfc130d5ea9af6f33da9b9802b8d1f
https://doi.org/10.1016/j.transproceed.2004.12.246
https://doi.org/10.1016/j.transproceed.2004.12.246
Autor:
Norio Yoshimura, Jean-Louis Touraine, Rikio Yoshimura, M. Matsuyama, Taro Hase, Jamel Chargui
Publikováno v:
Molecular medicine reports. 3(5)
Etodolac, a selective cyclooxygenase-2 (COX-2) inhibitor, is a non-steroidal anti-inflammatory drug. COX-2 is a key factor in the progression of inflammation. Although inflammation is an essential pathologic feature of cardiac allograft rejection, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d1bb1bc518c966593fc7bc624b0a84
https://pubmed.ncbi.nlm.nih.gov/21472312
https://pubmed.ncbi.nlm.nih.gov/21472312
Autor:
Yutaka Kawahito, K. Tsuchida, Junji Uchida, Yoshiaki Takemoto, T. Nakatani, Masahide Matsuyama, Rikio Yoshimura, Taro Hase, Hajime Sano
Publikováno v:
Transplantation proceedings. 37(4)
The pathogenesis of ischemia-reperfusion injury is known to involve cytokines and particularly surface adhesion molecules, the expression of which initiates the attachment of inflammatory cells. Peroxisome proliferator-activated receptor (PPAR)-gamma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::587d0e5833afc82b14a205143a6b1016
https://pubmed.ncbi.nlm.nih.gov/15919430
https://pubmed.ncbi.nlm.nih.gov/15919430
Autor:
Masahide Matsuyama, Yutaka Kawahito, Taro Hase, Hajime Sano, Masaki Kawamura, Rikio Yoshimura, Tatsuya Nakatani
Publikováno v:
Transplantation proceedings. 36(7)
Recent studies of ischemia-reperfusion (I/R) injury have focused on the function of neutrophils as well as the actions of inflammatory cytokines. However, few reports address cyclooxygenases (COXs) and lipoxygenases (LOXs). We researched the expressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bf25937866caf3b1afb46d08396343b
https://pubmed.ncbi.nlm.nih.gov/15518705
https://pubmed.ncbi.nlm.nih.gov/15518705